Blog
RSS FeedPosted by Michael Wonder on 29 Dec 2020
Vertex announces new drug submission for investigational triple combination medicine for the treatment of cystic fibrosis has been accepted for priority review by Health Canada
28 December 2020 - Vertex Pharmaceuticals Incorporated today announced its New Drug Submission for Trikafta, Vertex’s investigational triple combination medicine, ...
Posted by Michael Wonder on 04 Dec 2019
Health Canada grants priority review status for Heron Therapeutics' new drug submission for HTX-011 for management of post-operative pain
3 December 2019 - Heron Therapeutics today announced that Heron's new drug submission for HTX-011 for the management of postoperative pain ...
Posted by Michael Wonder on 20 Nov 2019
Medexus granted priority review status for Gliolan by Health Canada
19 November 2019 - Medexus Pharmaceuticals today announced that Health Canada has granted priority review status for the new drug ...
Posted by Michael Wonder on 25 Sep 2018
Alnylam Pharmaceuticals receives priority review in Canada for patisiran, an investigational RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
24 September 2018 - Health Canada grants priority review to promising medicines intended for the treatment of serious, debilitating or life-threatening ...
Posted by Michael Wonder on 12 Apr 2018
Health Canada accepts Mitsubishi Tanabe Pharma Corporation's NDS filing for edaravone to treat ALS, grants priority review
9 April 2018 - Mitsubishi Tanabe Pharma Canada launched in Toronto to prepare business operations. ...
Posted by Michael Wonder on 31 Oct 2017
Janssen announces Imbruvica (ibrutinib) as the first approved treatment for chronic graft-versus-host disease granted by Health Canada priority review
30 October 2017 - Approval provides a much-needed option for patients who develop this life-threatening condition following stem cell transplant. ...
Posted by Michael Wonder on 22 Mar 2016
Raptor's Procysbi new drug submission accepted by Health Canada with priority review
21 March 2016 - Raptor Pharmaceutical Corporation today announced that Health Canada has accepted for review its New Drug Submission for ...